4Hofmann S,Trnka HJ. General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty[J].Ortho pedics,1999,22 (2): 207-211.
5Khan SN,Bostrom MP, Lane JM. Bone growth factors[J]. Orthopedic clinics of north america, 2000, 31 (3) : 375.
6Spinella-Jaegle S,Poman-Roman S,Faucheu C,et al. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-β1 on osteoblast differ entiation[J].Bone,2001,29(4):323-330.
7Guicheux J,Lemonnier J,Ghayor C. Activation of p38 mitogen-activated protein kinase and C-Jun-NH2 terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation[J]. J Bone Miner Res,2003(11):2060-2068.
8Rosnzweig BL, Imarnura T, Okadome T. Cloning an characterization of a human type II receptor for bone morphogenetic proleins[J].Proc Nat Acad Sci USA,1995, 92(7):7632.
9Katagiri T, Yarnaguchi A, Ikeda T, et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibitis myogenic differ entiation in vitro[J].J Cell Biol,1991,113(3):681-687.
10Hiraki Y, lnoue H,Shigeno C. Bone morphogenetlc proteins(BMP-2 and BMP-3)promote growth and expression of the diferentiated phenolype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro[J].J bone Miner Res,1991,6(12):1373-1380.
